Form 8-K - Current report:
SEC Accession No. 0001628280-26-001773
Filing Date
2026-01-12
Accepted
2026-01-12 08:31:26
Documents
54
Period of Report
2026-01-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prme-20260112.htm   iXBRL 8-K 26392
2 EX-99.1 jan_2025xcorpxpres.htm EX-99.1 45331
6 jan_2025xcorpxpres001.jpg GRAPHIC 62692
7 jan_2025xcorpxpres002.jpg GRAPHIC 291234
8 jan_2025xcorpxpres003.jpg GRAPHIC 125338
9 jan_2025xcorpxpres004.jpg GRAPHIC 108044
10 jan_2025xcorpxpres005.jpg GRAPHIC 118767
11 jan_2025xcorpxpres006.jpg GRAPHIC 113004
12 jan_2025xcorpxpres007.jpg GRAPHIC 119065
13 jan_2025xcorpxpres008.jpg GRAPHIC 155635
14 jan_2025xcorpxpres009.jpg GRAPHIC 132465
15 jan_2025xcorpxpres010.jpg GRAPHIC 84107
16 jan_2025xcorpxpres011.jpg GRAPHIC 118397
17 jan_2025xcorpxpres012.jpg GRAPHIC 44054
18 jan_2025xcorpxpres013.jpg GRAPHIC 121667
19 jan_2025xcorpxpres014.jpg GRAPHIC 146659
20 jan_2025xcorpxpres015.jpg GRAPHIC 52176
21 jan_2025xcorpxpres016.jpg GRAPHIC 136309
22 jan_2025xcorpxpres017.jpg GRAPHIC 122982
23 jan_2025xcorpxpres018.jpg GRAPHIC 116069
24 jan_2025xcorpxpres019.jpg GRAPHIC 97604
25 jan_2025xcorpxpres020.jpg GRAPHIC 98766
26 jan_2025xcorpxpres021.jpg GRAPHIC 110613
27 jan_2025xcorpxpres022.jpg GRAPHIC 113480
28 jan_2025xcorpxpres023.jpg GRAPHIC 59736
29 jan_2025xcorpxpres024.jpg GRAPHIC 155237
30 jan_2025xcorpxpres025.jpg GRAPHIC 115820
31 jan_2025xcorpxpres026.jpg GRAPHIC 126532
32 jan_2025xcorpxpres027.jpg GRAPHIC 112893
33 jan_2025xcorpxpres028.jpg GRAPHIC 42149
34 jan_2025xcorpxpres029.jpg GRAPHIC 160670
35 jan_2025xcorpxpres030.jpg GRAPHIC 122525
36 jan_2025xcorpxpres031.jpg GRAPHIC 103635
37 jan_2025xcorpxpres032.jpg GRAPHIC 45089
38 jan_2025xcorpxpres033.jpg GRAPHIC 141648
39 jan_2025xcorpxpres034.jpg GRAPHIC 141273
40 jan_2025xcorpxpres035.jpg GRAPHIC 96856
41 jan_2025xcorpxpres036.jpg GRAPHIC 39589
42 jan_2025xcorpxpres037.jpg GRAPHIC 114940
43 jan_2025xcorpxpres038.jpg GRAPHIC 165383
44 jan_2025xcorpxpres039.jpg GRAPHIC 41878
45 jan_2025xcorpxpres040.jpg GRAPHIC 97527
46 jan_2025xcorpxpres041.jpg GRAPHIC 114061
  Complete submission text file 0001628280-26-001773.txt   6528915

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20260112.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20260112_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20260112_pre.xml EX-101.PRE 13055
56 EXTRACTED XBRL INSTANCE DOCUMENT prme-20260112_htm.xml XML 2913
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 26524821
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)